Literature DB >> 17116187

Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.

F Wotherspoon1, D W Laight, D L Browne, C Turner, D R Meeking, S E Allard, L J Munday, K M Shaw, M H Cummings.   

Abstract

AIMS: The purpose of this study was to examine the associations between endothelial function, plasma homocysteine and oxidative stress in patients with Type 1 diabetes mellitus (DM) and microalbuminuria compared with DM patients with normoalbuminuria and non-diabetic control subjects. We wished to test the hypothesis that increased cardiovascular risk in patients with Type 1 diabetes and microalbuminuria may be in part as a result of hyperhomocysteinaemia-mediated oxidative stress leading to impaired endothelial function.
METHODS: We measured forearm blood flow, total plasma homocysteine, total antioxidant status (TAOS) and whole blood glutathione in 31 DM patients, 16 with microalbuminuria and 15 with normoalbuminuria, and 15 non-diabetic control subjects.
RESULTS: Plasma homocysteine levels were significantly higher in the microalbuminuric diabetic patients compared with the normoalbuminuric patients and the control subjects. TAOS was significantly lower in the micoalbuminuric and normoalbuminuric diabetic patients compared with the control subjects, although TAOS levels were similar in both groups of diabetic patients. There was no difference in forearm blood flow between the groups and no association between measured endothelial function and antioxidant defence/oxidative stress and homocysteine in each group. There was no association between plasma total homocysteine and TAOS or whole blood glutathione within the groups.
CONCLUSIONS: We have found mild hyperhomocysteinaemia in microalbuminuric DM patients compared with normoalbuminuric DM patients and non-diabetic subjects and some evidence for reduced antioxidant defence in DM patients. These findings add to our understanding of the increased risk of vascular disease in patients with Type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116187     DOI: 10.1111/j.1464-5491.2006.01980.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  13 in total

1.  Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus.

Authors:  Karine Sahakyan; Barbara E K Klein; Kristine E Lee; Michael Y Tsai; Ronald Klein
Journal:  Eur J Endocrinol       Date:  2010-03-23       Impact factor: 6.664

2.  Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease.

Authors:  Charumathi Sabanayagam; Anoop Shankar
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

3.  Cardiovascular magnetic resonance imaging-based computational fluid dynamics/fluid-structure interaction pilot study to detect early vascular changes in pediatric patients with type 1 diabetes.

Authors:  Margaret M Samyn; Ronak Dholakia; Hongfeng Wang; Jennifer Co-Vu; Ke Yan; Michael E Widlansky; John F LaDisa; Pippa Simpson; Ramin Alemzadeh
Journal:  Pediatr Cardiol       Date:  2015-01-11       Impact factor: 1.655

4.  Folic acid, vitamin B12, and homocysteine levels during fasting and after methionine load in patients with Type 1 diabetes mellitus.

Authors:  A Giannattasio; M G Calevo; G Minniti; D Gianotti; M Cotellessa; F Napoli; R Lorini; G d'Annunzio
Journal:  J Endocrinol Invest       Date:  2010-10-15       Impact factor: 4.256

5.  Effect of zinc supplementation on serum homocysteine in type 2 diabetic patients with microalbuminuria.

Authors:  Esfandiar Heidarian; Massoud Amini; Mahmoud Parham; Ashraf Aminorroaya
Journal:  Rev Diabet Stud       Date:  2009-05-10

6.  A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism.

Authors:  Ian McDonald; Maureen Connolly; Anne-Marie Tobin
Journal:  J Nutr Metab       Date:  2012-05-29

7.  Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Elham Bahreini; Nadereh Rashtchizadeh; Hassan Argani; Samira Alizadeh
Journal:  Mol Vis       Date:  2010-12-06       Impact factor: 2.367

8.  Telomere length, antioxidant status and incidence of ischaemic heart disease in type 2 diabetes.

Authors:  Stefano Masi; Francesco D'Aiuto; Jackie Cooper; Klelia Salpea; Jeffrey W Stephens; Steven J Hurel; John E Deanfield; Steve E Humphries
Journal:  Int J Cardiol       Date:  2016-04-22       Impact factor: 4.164

9.  Serum Homocysteine and Total Antioxidant Status in Vitiligo: A Case Control Study in Indian Population.

Authors:  Shikha Gupta; Paschal D'souza; Tapan Kumar Dhali; Sarika Arora
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

10.  Hyperhomocysteinemia Alters Retinal Endothelial Cells Barrier Function and Angiogenic Potential via Activation of Oxidative Stress.

Authors:  Riyaz Mohamed; Isha Sharma; Ahmed S Ibrahim; Heba Saleh; Nehal M Elsherbiny; Sadanand Fulzele; Khaled Elmasry; Sylvia B Smith; Mohamed Al-Shabrawey; Amany Tawfik
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.